Related Experiment Video
Updated: Nov 30, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
Catherine S Spina1, Chizuru Tsuruoka2, Wendy Mao3
1Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Carbon-ion radiation therapy (CiRT) is generally lymphocyte-sparing at low doses, unlike photon therapy (PhRT). Higher doses of CiRT are more potent inducers of pro-inflammatory cytokines within the tumor microenvironment.
Area of Science:
- Radiation oncology
- Immunology
- Cancer research
Background:
- Radiation therapy (RT) impacts tumor microenvironment (TME) immunity.
- The differential immunomodulatory effects of various RT types remain unclear.
Purpose of the Study:
- To compare the immunomodulatory effects of carbon-ion therapy (CiRT) versus photon therapy (PhRT) on solid tumors.
- To investigate RT-induced changes in TME immune cell populations and cytokine profiles.
Main Methods:
- Orthotopic 4T1 mammary tumors in immunocompetent hosts were treated with CiRT or equivalent doses of PhRT.
- TME immune characteristics were quantified using flow cytometry and multiplex cytokine analysis 72 hours post-RT.
Main Results:
- PhRT decreased CD4+ and CD8+ T cells, while CiRT did not significantly alter CD8+ T-cell infiltration.
- High-dose CiRT elevated pro-inflammatory cytokines (granzyme B, IL-2, TNF-α) from CD8+ T cells; PhRT increased IFN-γ.
- PhRT increased regulatory T cell proliferation at most doses, whereas high-dose CiRT also induced this effect.
Conclusions:
- Low-dose CiRT is lymphocyte-sparing compared to PhRT.
- High-dose CiRT is a potent inducer of pro-inflammatory cytokines in the TME.
- CiRT warrants further investigation for its potential to modulate TME immunologic characteristics.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Biological Effects of Radiation

